Insmed Incorporated (BST:IM8N)

Insmed Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	27,412	31,613	11,930	4,011	2,533	2,835
Market Cap Growth	98.44%	164.99%	197.44%	58.36%	-10.67%	2.27%
Enterprise Value	26,835	30,813	11,633	4,522	2,829	2,620
Last Close Price	126.00	148.00	66.00	28.60	18.60	24.00
PS Ratio	53.07	61.21	33.96	14.53	11.03	17.11
PB Ratio	43.55	50.23	43.28	-13.36	30.78	7.86
P/TBV Ratio	60.93	70.27	104.23	-	-	13.27
EV/Sales Ratio	52.20	59.66	33.11	16.38	12.32	15.81
Debt / Equity Ratio	1.01	1.01	4.59	-4.09	15.08	1.49
Net Debt / Equity Ratio	-0.92	-0.92	-0.43	-1.74	2.02	-0.38
Net Debt / EBITDA Ratio	0.69	0.69	0.16	-0.87	-0.38	0.44
Net Debt / FCF Ratio	0.70	0.70	0.18	-1.05	-0.43	0.42
Asset Turnover	0.28	0.28	0.22	0.20	0.17	0.19
Inventory Turnover	1.07	1.07	0.94	0.86	0.81	0.76
Quick Ratio	3.35	3.35	4.99	3.64	6.19	5.48
Current Ratio	3.83	3.83	5.45	4.12	6.69	6.19
Return on Equity (ROE)	-249.28%	-249.28%	-	-	-193.22%	-126.66%
Return on Assets (ROA)	-28.99%	-28.99%	-29.30%	-28.50%	-20.61%	-22.50%
Return on Capital Employed (ROCE)	-55.40%	-55.40%	-45.50%	-61.70%	-32.60%	-33.10%
Earnings Yield	-3.97%	-3.44%	-7.40%	-16.91%	-17.79%	-13.48%
FCF Yield	-3.01%	-2.61%	-5.71%	-12.39%	-15.16%	-11.49%
Buyback Yield / Dilution	-21.32%	-21.32%	-16.81%	-14.14%	-9.74%	-14.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.